Potential survival benefit and early recovery from organ dysfunction with polymyxin B hemoperfusion: perspectives from a real-world big data analysis and the supporting mechanisms of action.

However, a nonsignificant trend in the median number of days alive and free of dialysis (20 days vs. 11 days; p = 0.59) and in the length of hospital stay (PMX-HP, 22.0 days vs. control 28 days; p = 0.15) was observed between both groups.

also in 5,406 other papers